- January 24, 2020 from 12:00-1:00 pm
- In-person: Ammon, Room 14
- On-line: Watch live at https://bluejeans.com/361095905
- Or join meeting ID 361095905 on the BlueJeans app on your smartphone or tablet
Lunch will be served. Please RSVP.
Although prostate cancer has a high overall survival rate, it remains a disease of disparities with few established risk factors beyond age, family history, and race. However, there is growing focus on modifiable risk factors. This talk will examine modifiable risk factors for adverse prostate cancer outcomes throughout the cancer continuum. Specifically, research examining the association between weight gain, obesity, smoking, and diabetes and adverse prostate cancer outcomes including prostate cancer aggressiveness, progression, and mortality will be discussed. Finally, ongoing research, utilizing national VA data, examining the chemotherapeutic potential of metformin and satins to improve survival outcomes in men with prostate cancer will be highlighted.
Meet the Speaker
Saira Khan, PhD, MPH is an Assistant Professor of Epidemiology at the College of Health Sciences at the University of Delaware. Prior to coming to University of Delaware, she was postdoctoral fellow in Cancer Prevention and Control at the Washington University in St. Louis School of Medicine. She received her PhD in Epidemiology from the University of North Carolina – Chapel Hill and a Masters in Public Health from Drexel University. She is a cancer epidemiologist, and her primary research focus is on reducing the burden of disparities in prostate cancer and elucidating risk factors for adverse prostate cancer outcomes.
This activity has been approved for AMA PRA Category 1 Credit